A uniquely-designed three-drug study has demonstrated that individual clinical characteristics, including patient preference, can be used to guide medication choice in type 2 diabetes. TriMaster is a ...

Allowing people with type 2 diabetes to try agents from three different classes of antidiabetes drugs showed they usually find a clear preference, often the drug that gives them the best glycemic ...

A largescale new study offers a new approach to treating in type 2 diabetes - that puts patients in charge of their own medication. The Trimaster study is the first to allow people with type 2 ...

GenNx360 Capital Partners has acquired Trimaster Manufacturing Inc. from Edgestone Capital Partners for an undisclosed amount. Trimaster is an Ontario-based maker of components and sub-assemblies for ...